Safety and Efficacy of Mesenchymal Stem Cells in Newly-diagnosed Type 1 Diabetic Patients

Clinical trial NCT01322789 · UNKNOWN

Trial details

NCT number: NCT01322789
Sponsor: University of Sao Paulo
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Insulin-Dependent

Start date: 2008-09-01
Primary completion: 2015-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.